Moreover, hypoglycaemia and weight gain [42] were closely associated with insulin therapy in T2D patients, in which the lower FBG target may lead to an insulin dose increase in T2D patients, which was a risk factor for hypoglycaemia and weight gain. The gene discussed is INS; the disease is Hypoglycemia.